Max Lenz
Impact in
-
- IL-33, ST2, and ILC Pathways
- Immune cells in cancer
- Atherosclerosis and Cardiovascular Diseases
- Immune Response and Inflammation
Papers in
-
- Immune cells in cancer 3
- IL-33, ST2, and ILC Pathways 2
- Co-authors
- Johann Wojta (29 shared papers)Walter S. Speidl (30 shared papers)Konstantin A. Krychtiuk (27 shared papers)Kurt Huber (22 shared papers)Gottfried Heinz (18 shared papers)Philipp J. Hohensinner (13 shared papers)Gerald Maurer (4 shared papers)Stefan Kastl (8 shared papers)
- Journals
- Journal of Clinical Medicine (6 papers)European Heart Journal Acute Cardiovascular Care (4 papers)Journal of Leukocyte Biology (2 papers)Journal of the American College of Cardiology (2 papers)Resuscitation (2 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Max Lenz
40 papers receiving 388 citations
Peers
Comparison fields: 5 of 62
- Immunology 107
- Cardiology and Cardiovascular Medicine 67
- Critical Care and Intensive Care Medicine 13
- Emergency Medicine 21
- Nephrology 15
Countries citing papers authored by Max Lenz
This map shows the geographic impact of Max Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Lenz more than expected).
Fields of papers citing papers by Max Lenz
This network shows the impact of papers produced by Max Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Lenz. The network helps show where Max Lenz may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Lenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 58 | |
| 2 | 2015 | 35 | |
| 3 | 2018 | 25 | |
| 4 | 2017 | 25 | |
| 5 | 2021 | 22 | |
| 6 | 2016 | 20 | |
| 7 | 2019 | 19 | |
| 8 | 2021 | 18 | |
| 9 | 1974 | 14 | |
| 10 | 2020 | 14 | |
| 11 | 2017 | 13 | |
| 12 | 2018 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2022 | 10 | |
| 16 | 2023 | 10 | |
| 17 | 2019 | 9 | |
| 18 | 2020 | 9 | |
| 19 | 2018 | 7 | |
| 20 | 2019 | 7 |
About Max Lenz
Max Lenz is a scholar working on Cardiology and Cardiovascular Medicine, Immunology, Surgery, Epidemiology and Molecular Biology, having authored 48 papers that have together received 400 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (4 papers), Immune cells in cancer (3 papers), Sepsis Diagnosis and Treatment (3 papers), Cardiac Arrest and Resuscitation (3 papers), Receptor Mechanisms and Signaling (2 papers), Eosinophilic Esophagitis (2 papers), Mechanical Circulatory Support Devices (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). The work is most often cited by research in Immunology (107 citations), Cardiology and Cardiovascular Medicine (67 citations), Critical Care and Intensive Care Medicine (13 citations), Emergency Medicine (21 citations) and Nephrology (15 citations). Max Lenz has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Johann Wojta, Walter S. Speidl, Konstantin A. Krychtiuk, Kurt Huber, Gottfried Heinz, Philipp J. Hohensinner, Gerald Maurer, Stefan Kastl, Christoph Kaun and Lorenz Koller. Their work appears in journals such as Journal of Clinical Medicine, European Heart Journal Acute Cardiovascular Care, Journal of Leukocyte Biology, Journal of the American College of Cardiology and Resuscitation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.